Zacks Research Issues Pessimistic Estimate for THC Earnings

Tenet Healthcare Co. (NYSE:THC) – Equities researchers at Zacks Research lowered their Q1 2026 earnings per share estimates for shares of Tenet Healthcare in a research report issued on Wednesday, March 26th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $3.43 per share for the quarter, down from their prior estimate of $3.45. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q4 2026 earnings at $3.56 EPS and FY2026 earnings at $13.40 EPS.

THC has been the subject of several other research reports. Barclays cut their price target on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating for the company in a report on Thursday, February 13th. TD Cowen initiated coverage on shares of Tenet Healthcare in a research note on Wednesday, February 26th. They set a “buy” rating and a $175.00 price target on the stock. Morgan Stanley assumed coverage on shares of Tenet Healthcare in a report on Wednesday. They issued an “overweight” rating and a $165.00 target price on the stock. StockNews.com raised shares of Tenet Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, March 13th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $177.00 price objective on shares of Tenet Healthcare in a research report on Thursday, February 13th. Three investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare has a consensus rating of “Moderate Buy” and an average target price of $166.41.

Tenet Healthcare Price Performance

Shares of NYSE:THC opened at $133.17 on Friday. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. The firm has a market cap of $12.67 billion, a price-to-earnings ratio of 4.13, a P/E/G ratio of 1.02 and a beta of 2.06. The firm has a fifty day moving average price of $132.43 and a 200 day moving average price of $142.50. Tenet Healthcare has a fifty-two week low of $90.03 and a fifty-two week high of $171.20.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the company’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the sale, the director now directly owns 27,378 shares in the company, valued at approximately $3,434,022.54. This represents a 25.81 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.93% of the stock is owned by corporate insiders.

Institutional Trading of Tenet Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the company. Colonial Trust Co SC raised its holdings in shares of Tenet Healthcare by 85.7% in the 4th quarter. Colonial Trust Co SC now owns 247 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares in the last quarter. GeoWealth Management LLC raised its stake in Tenet Healthcare by 39.8% in the fourth quarter. GeoWealth Management LLC now owns 295 shares of the company’s stock worth $37,000 after buying an additional 84 shares in the last quarter. True Wealth Design LLC bought a new position in Tenet Healthcare in the third quarter worth about $38,000. WR Wealth Planners LLC lifted its position in shares of Tenet Healthcare by 2,836.4% during the fourth quarter. WR Wealth Planners LLC now owns 323 shares of the company’s stock valued at $41,000 after buying an additional 312 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its position in shares of Tenet Healthcare by 30.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 471 shares of the company’s stock worth $59,000 after buying an additional 110 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.